News & Reports 2017-04-05T16:38:50+00:00

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Why UO’s Knight Campus will boost Oregon’s fortunes (guest column)

The $1B project still needs lawmakers to approve $100M in bonds, an investment its new director says will bring together the whole state.

Patrick Phillips

The University of Oregon will break ground on the $1 billion Phil and Penny Knight Campus for Accelerating Scientific Impact this fall —made possible by a $500 million donation from the Knights — and the labs, classrooms, prototyping space and other core facilities will be the foundation for new scientific activities that […]

June 23rd, 2017|

Portland biotech startup foresees rapid growth from HIV test

Elizabeth Hayes, Staff Reporter, Portland Business Journal

Typically, an HIV diagnostic test takes a few hours to run and requires a laboratory.

A Portland biosciences company is developing a hand-held test that can produce accurate results from a drop of blood in just 20 minutes — and estimate how recently the infection occurred.

Sedia Biosciences Corp.’s rapid HIV test could potentially speed up diagnosis of the disease, especially in developing countries, and play a big role in slowing […]

June 21st, 2017|

Drug price transparency bill will not lower Rx costs

Why is drug price transparency legislation like the wolf in “Little Red Riding Hood”? It was because the wolf was pretending to be something he was not. Equally, there is state legislation that is pretending to be about transparency in drug pricing when it is really about limiting the profitability of biotech firms. That kind of government control would deter investment in new and innovative biopharmaceutical treatments.

Under a bill introduced […]

May 19th, 2017|

DesignMedix’s malaria drug to enter clinical trials with support from NIH


CONTACT: Sandra Shotwell, CEO,, 503-348-0855

Portland OR: DesignMedix Inc., a drug development company targeting drug resistant infectious diseases, has entered into an agreement with the National Institutes of Health (NIH) that will pave the way for first-in-human clinical trials of DesignMedix’s malaria drug DM1157. The agreement is with the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, and builds on the strong package […]

April 10th, 2017|

Grant-supported interns available for your company

Oregon Bio is excited to partner with OHSU and OSU to connect member companies with qualified interns.

We will help match your needs to highly motivated and qualified undergraduate and graduate level interns from OSU and OHSU. Timing for Ph.D. students can be flexible, by mutual arrangement.

For more information, please contact Lynn Ekstedt,


April 6th, 2017|


The government is taking another step to reduce the regulatory burden on physicians--this time with fewer, more targeted Medicare audits. Doctors who have sound billing habits are likely to get some r [...]

Cleveland Clinic's James Stoller, M.D., describes the current healthcare environment using the military acronym "VUCA," which stands for "volatile, uncertain, confusing and ambiguo [...]

Blade Therapeutics is looking to sharpen its focus after hiring Bristol-Myers Squibb's former fibrosis research lead as its new EVP of research. The biotech, which is working on antifibrotic (sca [...]

Former Zealand Pharma chief David Horn Solomon, M.D., has taken up the challenge of guiding biotech Akari during an increasingly tumultuous period. [...]

Sen. Dean Heller (R-Nev.) says in a new interview that he hopes ObamaCare repeal comes back up and Republicans can find the 50th vote to pass it."Once we have 50 votes healthcare will come up aga [...]

AstraZeneca has expanded its mRNA activities through an agreement with Ethris. The Big Pharma is paying €25 million ($29 million) upfront to work with Ethris on respiratory diseases and secure the o [...]

NEW YORK (AP) -- Herbalife says that it was in talks to be acquired and taken private, but that those negotiations ended last week. The nutritional supplement company said Monday that in response to t [...]

WASHINGTON (AP) -- Don’t make things worse. That’s the advice of former U.S. health secretaries of both parties to President Donald Trump and the GOP-led Congress, now that “Obamacare” seems here for [...]